Stocksigma LogoStocksigma Logo

Neochem Bio Solutions Delivers Strong FY26 Growth With Expanding Margins

Neochem Bio Solutions reported FY26 revenue from operations of ₹110.7 crore, up 32% YoY (35% 2-year CAGR), driven by domestic strength and expanding

Neochem Bio Solutions Delivers Strong FY26 Growth With Expanding Margins

Neochem Bio Solutions Ltd · Intimation · 23 Sept 2026, 9:05 pm

Neochem Bio Solutions Delivers Strong FY26 Growth With Expanding Margins Neochem Bio Solutions reported FY26 revenue from operations of ₹110.7 crore, up 32% YoY (35% 2-year CAGR), driven by domestic strength and expanding end-market applications. EBITDA surged 53% YoY to ₹22.6 crore with margins expanding 321 bps YoY to 20.4%, while PAT jumped 62% YoY to ₹12.0 crore. Capacity utilization at its 22,000 MTPA Ahmedabad plant rose to 52.7% from 41.8% in FY25. The company deleveraged significantly, reducing its net debt-to-equity ratio to 0.2x following its ₹42.7 crore IPO on NSE SME.

Original exchange filing (PDF)

More announcements from Neochem Bio Solutions Ltd

All Neochem Bio Solutions Ltd announcements